Mark Murphy
5Patents
2h-index
13Co-inventors
48Inventor score
Filing activity: Aug 10, 1993 → Jan 18, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5438142A | Functionalized tris(hydroxyphenyl) compounds | Chemistry; Metallurgy | 8 | Expired |
| US9221832B2 | Heterocyclic amide derivatives as P2X7 receptor antagonists | Chemistry; Metallurgy | 4 | Active |
| US11608341B2 | Substituted tetrahydropyrazolo[3,4-d]pyrimidines and tetrahydropyrazolo[4,3-d]pyrimidines as C5A receptor modulators | Human Necessities | 0 | Active |
| US11685729B2 | C5a receptor modulators | Chemistry; Metallurgy | 0 | Active |
| US11739070B2 | C5A receptor modulators | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.